• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The Presence of anti-PEG IgM and its effect on pharmacokinetics in Human on Injection of PLD to Ovarian Cancer Patients

Research Project

Project/Area Number 17K11269
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Obstetrics and gynecology
Research InstitutionThe University of Tokyo

Principal Investigator

Matsumoto Yoko  東京大学, 医学部附属病院, 登録研究員 (10466758)

Project Period (FY) 2017-04-01 – 2020-03-31
Project Status Completed (Fiscal Year 2019)
Budget Amount *help
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2019: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
KeywordsDDS / ABC現象 / ドキシル / PLD / 抗PEG抗体 / 卵巣癌 / ドラッグデリバリーシステム / 化学療法
Outline of Final Research Achievements

Polyethylene glycol (PEG) is widely used for modification of drug carriers. Although PEG was supposed to have low immunogenicity, accelerated blood clearance of the PEGylated reagent through production of anti-PEG IgM was reported in animals. To assess the significance of anti-PEG IgM in treatments with PLD, clinical data and blood serum samples of 17 ovarian cancer patients were obtained under approval of our institutional ethics committee. Among 17 patients, five had anti-PEG IgM prior to PLD injections. The initial production of anti-PEG IgM was not detected. In IgM positive patients, anti-PEG IgM was consumed by injection of PLD and significantly decreased (p=0.001), but recovered by next treatment. The concentrations of PLD in blood serum 20 hours after injections and quantities of anti-PEG IgM had no correlations. Disease control rates at 16 weeks and non-hematological grade 3/4 adverse events in IgM positive and negative groups were not significantly distinct.

Academic Significance and Societal Importance of the Research Achievements

近年急速に発展しているDDS技術を用いた医薬品のヒトでの体内動態が、その構造、成分によって影響を受け、理論通りとならない可能性についての研究は少ない。今後益々汎用性が増加する技術であり、繊細な構造が重要となることからも今回のABC現象のような解析は必要不可欠であると考える。また

Report

(4 results)
  • 2019 Annual Research Report   Final Research Report ( PDF )
  • 2018 Research-status Report
  • 2017 Research-status Report
  • Research Products

    (7 results)

All 2020 2019 2018 2017

All Journal Article (1 results) (of which Peer Reviewed: 1 results,  Open Access: 1 results) Presentation (6 results) (of which Invited: 1 results)

  • [Journal Article] Interleukin-17 is associated with expression of programmed cell death 1 ligand 1 in ovarian carcinoma.2019

    • Author(s)
      Aotsuka A, Matsumoto Y, Arimoto T, Kawata A, Ogishima J, Taguchi A, Tanikawa M, Sone K, Mori-Uchino M, Tsuruga T, Oda K, Kawana K, Osuga Y, Fujii T.
    • Journal Title

      Cancer Sci.

      Volume: 110 Issue: 10 Pages: 3068-3078

    • DOI

      10.1111/cas.14174

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access
  • [Presentation] Enhanced anti-tumor activity by combination of Lipid Bubble-Ultrasound and anticancer drugs in gynecological cancers2020

    • Author(s)
      Kohei Yamaguchi, Yoko Matsumoto, Haruka Nishida, Hirofumi Inaba, Asako Kukita, Michihiro Tanikawa, Kenbun Sone, Katsutoshi Oda, Yutaka Osuga, Tomoyuki Fujii
    • Organizer
      第72回日本産科婦人科学会学術講演会
    • Related Report
      2019 Annual Research Report
  • [Presentation] 卵巣悪性腫瘍との鑑別に審査腹腔鏡による腹腔内所見採取が有用であった異型子宮内膜症の一例2018

    • Author(s)
      松本陽子
    • Organizer
      題8回日本産科婦人科内視鏡学会
    • Related Report
      2018 Research-status Report
  • [Presentation] ヒトにおける抗PEG IgM抗体の産生とPLD投与への影響2018

    • Author(s)
      松本陽子
    • Organizer
      筑波大学 バイオマテリアルセミナー
    • Related Report
      2018 Research-status Report
    • Invited
  • [Presentation] 子宮頸癌の予防と治療~ HPVワクチンから新規治療薬の開発まで2018

    • Author(s)
      松本陽子
    • Organizer
      第4回徳島大学薬学部BRIGHT symposium
    • Related Report
      2018 Research-status Report
  • [Presentation] ドキシルの副作用に関する検討2018

    • Author(s)
      松本陽子
    • Organizer
      日本薬剤学会第5回種差検討会
    • Related Report
      2017 Research-status Report
  • [Presentation] ドキシルの臨床現場での使用経験2017

    • Author(s)
      松本陽子
    • Organizer
      日本DDS学会
    • Related Report
      2017 Research-status Report

URL: 

Published: 2017-04-28   Modified: 2021-02-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi